Recombinant human erythropoietin
Recombinant human erythropoietin is a pharmaceutical drug with 20 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
3
Early Stage
2
Mid Stage
10
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
13 of 13 finished
0.0%
0 ended early
0
trials recruiting
20
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Traumatic Optic Neuropathy Treatment Trial 2
Decitabine for Poor Graft Function Post Allo-HSCT
Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
Tracing Changed Production of Red Blood Cells
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
Clinical Trials (20)
Traumatic Optic Neuropathy Treatment Trial 2
Decitabine for Poor Graft Function Post Allo-HSCT
Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT
Tracing Changed Production of Red Blood Cells
The Effectiveness of Lactoferrin in the Management of Treatment-induced Anemia
Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants
Clinical Study the Efficacy and Safety of Rh-EPO in the Treatment of Anemia in Lymphoma
Comparison of Darbepoetin Alpha and Recombinant Human Erythropoietin for Treatment of Anemia in Children With Chronic Kidney Disease
Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants
Does Erythropoietin Improve Outcome in Very Preterm Infants?
Safety and Efficacy of Multiple EPO Injections in Children With Cerebral Palsy
Effect of Erythropoietin on Preterm Brain Injury
A Pharmacokinetic And Pharmacodynamic Study Of Oral Lenalidomide (Revlimid) In Subjects With Low- Or Intermediate-1-Risk Myelodysplastic Syndromes
Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest
Identification of New Serum Markers for Detection of Abuse With Erythropoietin
Can Erythropoietin Protect the Cerebral Blood Flow and Oxygenation During Simulated Dive?
A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
Neurological Outcome After Erythropoietin Treatment for Neonatal Encephalopathy
Treatment for Patients Suffering From Anemia Due to Chemotherapy
All 20 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 20